Rheumatology News and Research

RSS
Rheumatology is a sub-specialty in internal medicine and pediatrics, devoted to the diagnosis and therapy of rheumatic diseases. Rheumatologists mainly deal with clinical problems involving joints, soft tissues and allied conditions of connective tissues.
Manchester researchers launch new project to better understand causes of RA

Manchester researchers launch new project to better understand causes of RA

Research findings suggest potent new therapeutic target for certain types of cancer

Research findings suggest potent new therapeutic target for certain types of cancer

Surgeon provides guidance to identify ways to manage patients with sleep apnea

Surgeon provides guidance to identify ways to manage patients with sleep apnea

TWi Biotechnology completes patient enrollment in phase II trial of AC-201 for Gout Flare Prophylaxis

TWi Biotechnology completes patient enrollment in phase II trial of AC-201 for Gout Flare Prophylaxis

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Mayo researchers find rheumatic condition gout may be due to flare-ups in other joints

Mayo researchers find rheumatic condition gout may be due to flare-ups in other joints

Anatomy of a Hospital: New book chronicles history of nation's oldest hospital for orthopedics

Anatomy of a Hospital: New book chronicles history of nation's oldest hospital for orthopedics

Celgene reports results from placebo-controlled phase II trial in patients with Behçet's disease

Celgene reports results from placebo-controlled phase II trial in patients with Behçet's disease

Study demonstrates efficacy of canakinumab at tapering corticosteroid use in patients with SJIA

Study demonstrates efficacy of canakinumab at tapering corticosteroid use in patients with SJIA

EULAR announces recipients of Meritorious Service Award

EULAR announces recipients of Meritorious Service Award

Overweight, obese ERA patients require twice as much drug therapy to achieve successful remission

Overweight, obese ERA patients require twice as much drug therapy to achieve successful remission

Ischaemic heart disease patients at risk after 1 week of treatment

Ischaemic heart disease patients at risk after 1 week of treatment

Novel antibody biomarkers could significantly improve diagnosis in RA, study shows

Novel antibody biomarkers could significantly improve diagnosis in RA, study shows

Data demonstrate benefits of nurse-led programme on patient self-management of RA

Data demonstrate benefits of nurse-led programme on patient self-management of RA

Study: Tocilizumab is effective in children with juvenile idiopathic arthritis

Study: Tocilizumab is effective in children with juvenile idiopathic arthritis

AMPLE trial demonstrates similar safety profiles and efficacy between abatacept and adalimumab in RA

AMPLE trial demonstrates similar safety profiles and efficacy between abatacept and adalimumab in RA

Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

Apremilast continues to demonstrate meaningful clinical responses in patients with psoriatic arthritis

Apremilast continues to demonstrate meaningful clinical responses in patients with psoriatic arthritis

Study demonstrates efficacy of ARASHI method at evaluating radiographic joint damage in RA

Study demonstrates efficacy of ARASHI method at evaluating radiographic joint damage in RA

Using Swiss ball improves walking performance and muscle strength in AS patients

Using Swiss ball improves walking performance and muscle strength in AS patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.